RGC Resources director John B. Williamson III acquires $2,374 in shares
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- RGCO Rgc Resources-1.6% 9d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Regencell Bioscience Holdings belongs to, so it often moves with news about it.
- RGC Regencell Bioscience Holdings+17.2% 6d
Regencell Bioscience Holdings is a peer of Regencell Bioscience Holdings in medicinal chemicals and botanical products; rivals often move on the same news.
- DFTX Definium Therapeutics-13.3% 30d
Definium Therapeutics is a peer of Regencell Bioscience Holdings in medicinal chemicals and botanical products; rivals often move on the same news.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a large health company like Regencell Bioscience Holdings; big names in a sector often move together.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a large health company like Regencell Bioscience Holdings; big names in a sector often move together.
- ABBV AbbVie+12.0% 30d
AbbVie is a large health company like Regencell Bioscience Holdings; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RGCO | +1.18% | +0.00% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| RGC | +7.83% | +10.89% | base | after close | after close | after close | after close |
| DFTX | +10.25% | +7.39% | base | after close | after close | after close | after close |
| LLY | -2.25% | -0.49% | base | after close | after close | after close | after close |
| JNJ | -1.35% | -1.97% | base | after close | after close | after close | after close |
| ABBV | -0.57% | -0.04% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
RGC Resources director John B. Williamson III acquires $2,374 in shares Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -0.04% | final price |
| ABBV | five days earlier | -0.57% | final price |
| DFTX | three days earlier | +7.39% | final price |
| DFTX | five days earlier | +10.25% | final price |
| JNJ | three days earlier | -1.97% | final price |
| JNJ | five days earlier | -1.35% | final price |
| LLY | three days earlier | -0.49% | final price |
| LLY | five days earlier | -2.25% | final price |
| RGC | three days earlier | +10.89% | final price |
| RGC | five days earlier | +7.83% | final price |
| RGCO | three days earlier | 0.00% | final price |
| RGCO | five days earlier | +1.18% | final price |
| XLV | three days earlier | +0.04% | final price |
| XLV | five days earlier | -0.28% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 12 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 26 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 72 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 39 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 46 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 51 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 39 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 62 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 72 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“RGC Resources director John B. Williamson III acquires $2,374 in shares” scores 12 out of 100. The score uses 1 sources.